新型阿迪波金 (FAM19A5) 通过素-1-酸盐受体2抑制了受伤后的新心形成
Yingbao Wang1, Dixin Chen1,2, Yan Zhang2
1Department of Physiology and Pathophysiology (Y.W., D.C., S.Z., B.Y., L.Z., G.Z., B.M., Z.C., N.X., Z.L., X.W., Y.F., W.K.).
Circulation
|February 18, 2018
概括
一种新发现的阿迪波金,家族与序列相似性19,成员A5 (FAM19A5),抑制了血管损伤反应. 肥胖的FAM19A5降低可能导致心脏代谢疾病.
科学领域:
- 内分泌学
- 心血管生物学
- 分子生物学
背景情况:
- 肥胖是心血管疾病的重要危险因素, 但根本的机制尚未完全理解.
- 脂肪组织中的信号分子阿迪波金与肥胖相关的心血管并发症有关.
- 鉴定出了一种新型的阿迪波金家族,其序列相似性为19号,成员A5 (FAM19A5),其在血管病理中的作用尚未被探索.
研究的目的:
- 研究新型阿迪波金FAM19A5在受伤后调节血管病理中的功能.
- 确定FAM19A5对血管细胞施加作用的分子机制和受体.
主要方法:
- 使用分子生物学技术对FAM19A5分泌和表达的描述.
- 在老鼠和小鼠中使用气球和电线损伤模型进行体内研究,以评估新密度的形成.
- 使用生物信息学,结合测定和细胞信号分析识别FAM19A5受体.
主要成果:
- FAM19A5 是脂肪组织中分泌的蛋白质,在肥胖中下调.
- 过度表达FAM19A5抑制了血管光滑肌细胞的增殖,迁移和新密细胞的形成.
- 被确定为FAM19A5的功能性受体,通过G12/13-RhoA通路调解其作用.
结论:
- 新型阿迪波金FAM19A5通过S1PR2-G12/13-RhoA信号轴抑制受伤后的新内形成.
- 肥胖症中FAM19A5的降低可能是导致心脏代谢疾病的因素.
相关概念视频
Predicting Products: SN1 vs. SN2
17.4K
Nucleophilic substitution reactions of alkyl halides can proceed via an SN1 or an SN2 mechanism. While in SN2 reactions, the nucleophile attacks the substrate simultaneously as the leaving group departs, in SN1 reactions, the substrate first dissociates to give the carbocation intermediate. Various factors such as the structure of the substrate, the strength of the nucleophile, and the nature of the solvent promote one mechanism over the other.
With increased substitution on the alkyl halide,...
With increased substitution on the alkyl halide,...
17.4K
Feedback Inhibition
57.4K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.4K
Phosphate Buffer
5.4K
The phosphate buffer system is a critical biological mechanism for maintaining pH stability in the body. This system operates primarily through two components: sodium dihydrogen phosphate (NaH2PO4), which acts as a weak acid, and sodium hydrogen phosphate (Na2HPO4), which serves as a weak base.
Sodium dihydrogen phosphate does not fully dissociate in neutral or acidic solutions. When a strong base, such as sodium hydroxide (NaOH), is introduced into the solution, sodium dihydrogen phosphate...
Sodium dihydrogen phosphate does not fully dissociate in neutral or acidic solutions. When a strong base, such as sodium hydroxide (NaOH), is introduced into the solution, sodium dihydrogen phosphate...
5.4K
Enzyme-linked Receptors
86.8K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
86.8K
Receptor-mediated Endocytosis
111.6K
Overview
111.6K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
652
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
652


